Cockayne syndrome group B protein prevents the accumulation of damaged mitochondria by promoting mitochondrial autophagy

M Scheibye-Knudsen, M Ramamoorthy… - Journal of Experimental …, 2012 - rupress.org
M Scheibye-Knudsen, M Ramamoorthy, P Sykora, S Maynard, PC Lin, RK Minor…
Journal of Experimental Medicine, 2012rupress.org
Cockayne syndrome (CS) is a devastating autosomal recessive disease characterized by
neurodegeneration, cachexia, and accelerated aging. 80% of the cases are caused by
mutations in the CS complementation group B (CSB) gene known to be involved in DNA
repair and transcription. Recent evidence indicates that CSB is present in mitochondria,
where it associates with mitochondrial DNA (mtDNA). We report an increase in metabolism
in the CSBm/m mouse model and CSB-deficient cells. Mitochondrial content is increased in …
Cockayne syndrome (CS) is a devastating autosomal recessive disease characterized by neurodegeneration, cachexia, and accelerated aging. 80% of the cases are caused by mutations in the CS complementation group B (CSB) gene known to be involved in DNA repair and transcription. Recent evidence indicates that CSB is present in mitochondria, where it associates with mitochondrial DNA (mtDNA). We report an increase in metabolism in the CSBm/m mouse model and CSB-deficient cells. Mitochondrial content is increased in CSB-deficient cells, whereas autophagy is down-regulated, presumably as a result of defects in the recruitment of P62 and mitochondrial ubiquitination. CSB-deficient cells show increased free radical production and an accumulation of damaged mitochondria. Accordingly, treatment with the autophagic stimulators lithium chloride or rapamycin reverses the bioenergetic phenotype of CSB-deficient cells. Our data imply that CSB acts as an mtDNA damage sensor, inducing mitochondrial autophagy in response to stress, and that pharmacological modulators of autophagy are potential treatment options for this accelerated aging phenotype.
rupress.org
以上显示的是最相近的搜索结果。 查看全部搜索结果